# VENTX

## Overview
The VENTX gene encodes the VENT homeobox protein, a transcription factor that belongs to the homeobox family, which is characterized by its role in regulating gene expression during development and differentiation. This protein is particularly significant in the context of hematopoiesis, where it influences the differentiation and proliferation of hematopoietic stem and progenitor cells. VENTX is involved in the modulation of key signaling pathways, including the Wnt signaling pathway, and interacts with various transcription factors to regulate cellular processes such as cell cycle progression and immune response. Its expression and activity are critical in both normal physiological processes and pathological conditions, including hematological malignancies and autoimmune diseases, where it can act as either a promoter of differentiation or a tumor suppressor, depending on the cellular context (Wu2011The; Rawat2010The; Gao2010VentX).

## Structure


## Function
The VENTX gene encodes a homeobox transcription factor that plays a crucial role in the regulation of hematopoietic stem/multipotent progenitor cells (HSC/MPPs) and myeloid differentiation in healthy human cells. VENTX functions as an anti-proliferation and pro-differentiation factor, influencing the expansion and differentiation of hematopoietic cells. It is involved in the regulation of the Wnt signaling pathway and cell cycle components, such as cyclin D1, p21, and p16^ink4a, which are critical for controlling the proliferation of CD34+ hematopoietic cells (Gao2012Suppression).

VENTX is highly expressed in myeloid cells and promotes myeloid differentiation by initiating genes related to myeloid development while down-regulating those involved in early lymphoid development (Rawat2010The). It is also essential for the differentiation of monocytes into macrophages, where it regulates the expression of macrophage markers and enhances proinflammatory activation (Wu2011The). In dendritic cells, VENTX is involved in differentiation and function, influencing the expression of genes specific to conventional dendritic cells (Nagel2021NKL).

## Clinical Significance
Alterations in the expression of the VENTX gene have been implicated in various diseases, particularly hematological malignancies and autoimmune conditions. In acute myeloid leukemia (AML), VENTX is highly expressed, especially in leukemic CD34+ cells, and its overexpression promotes myeloid differentiation while suppressing lymphoid and erythroid development. This aberrant expression is associated with the myeloid phenotype of AML, and knockdown of VENTX in AML cell lines reduces their proliferation, indicating its role in leukemic cell growth (Rawat2010The).

In chronic lymphocytic leukemia (CLL), VENTX acts as a tumor suppressor by inhibiting the Wnt/β-catenin signaling pathway, which reduces cell proliferation. Its expression is significantly downregulated in CLL, correlating with increased levels of cyclin D1, a cell cycle regulator (Gao2010VentX).

VENTX also plays a role in autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its expression correlates with elevated levels of proinflammatory cytokines in these conditions, suggesting that dysregulated VENTX expression may contribute to their pathogenesis. Immunosuppressive treatments have been shown to reduce VENTX expression, indicating its potential as a therapeutic target (Wu2011The).

## Interactions
VENTX, a homeobox transcription factor, participates in several interactions with proteins and nucleic acids that are crucial for its regulatory functions. VENTX interacts with lymphoid-enhancing factor/T-cell factor (LEF/TCF) transcriptional factors, specifically TCF4 and LEF1, forming complexes that inhibit β-catenin transactivation of LEF/TCF-mediated transcription. This interaction disrupts the formation of the β-catenin and TCF4 complex, thereby inhibiting β-catenin/LEF/TCF signaling (Gao2010VentX).

VENTX also binds directly to the promoters of specific genes, such as p53 and p16^ink4a, trans-activating these pathways to regulate cellular senescence and tumor suppression. This binding is confirmed through ChIP assays, indicating a direct interaction with the p53 promoter (Wu2011VentX).

In the context of dendritic cell differentiation, VENTX is activated by transcription factors like SPI1 and IRF2, while being repressed by SPIB. It also interacts with signaling pathways such as CSF-, NOTCH-, TNFa-, and IL4-signaling, which mediate its activation (Nagel2021NKL).

These interactions highlight VENTX's role in modulating transcriptional activity and its involvement in cell differentiation and immune response regulation.


## References


[1. (Rawat2010The) Vijay P. S. Rawat, Natalia Arseni, Farid Ahmed, Medhanie A. Mulaw, Silvia Thoene, Bernhard Heilmeier, Tim Sadlon, Richard J. D’Andrea, Wolfgang Hiddemann, Stefan K. Bohlander, Christian Buske, and Michaela Feuring-Buske. The vent-like homeobox gene ventx promotes human myeloid differentiation and is highly expressed in acute myeloid leukemia. Proceedings of the National Academy of Sciences, 107(39):16946–16951, September 2010. URL: http://dx.doi.org/10.1073/pnas.1001878107, doi:10.1073/pnas.1001878107. This article has 27 citations.](https://doi.org/10.1073/pnas.1001878107)

[2. (Wu2011The) Xiaoming Wu, Hong Gao, Weixiong Ke, Roger W. Giese, and Zhenglun Zhu. The homeobox transcription factor ventx controls human macrophage terminal differentiation and proinflammatory activation. Journal of Clinical Investigation, 121(7):2599–2613, July 2011. URL: http://dx.doi.org/10.1172/jci45556, doi:10.1172/jci45556. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci45556)

[3. (Nagel2021NKL) Stefan Nagel, Claudia Pommerenke, Corinna Meyer, and Hans G. Drexler. Nkl homeobox gene ventx is part of a regulatory network in human conventional dendritic cells. International Journal of Molecular Sciences, 22(11):5902, May 2021. URL: http://dx.doi.org/10.3390/ijms22115902, doi:10.3390/ijms22115902. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22115902)

[4. (Wu2011VentX) Xiaoming Wu, Hong Gao, Weixiong Ke, Martin Hager, Sheng Xiao, Michael R. Freeman, and Zhenglun Zhu. Ventx trans-activates p53 and p16ink4a to regulate cellular senescence. Journal of Biological Chemistry, 286(14):12693–12701, April 2011. URL: http://dx.doi.org/10.1074/jbc.m110.206078, doi:10.1074/jbc.m110.206078. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m110.206078)

[5. (Gao2012Suppression) Hong Gao, Xiaoming Wu, Yan Sun, Shuanhu Zhou, Leslie E. Silberstein, and Zhenglun Zhu. Suppression of homeobox transcription factor ventx promotes expansion of human hematopoietic stem/multipotent progenitor cells. Journal of Biological Chemistry, 287(35):29979–29987, August 2012. URL: http://dx.doi.org/10.1074/jbc.m112.383018, doi:10.1074/jbc.m112.383018. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m112.383018)

[6. (Gao2010VentX) Hong Gao, Yi Le, Xiaoming Wu, Leslie E. Silberstein, Roger W. Giese, and Zhenglun Zhu. Ventx, a novel lymphoid-enhancing factor/t-cell factor–associated transcription repressor, is a putative tumor suppressor. Cancer Research, 70(1):202–211, January 2010. URL: http://dx.doi.org/10.1158/0008-5472.can-09-2668, doi:10.1158/0008-5472.can-09-2668. This article has 29 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-09-2668)